TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
27,329
|
27,654
|
24,075 |
| Financial expenses |
899
|
734
|
17,488 |
| Earnings before taxes |
-571
|
3,208
|
-11,818 |
| Total assets |
38,685
|
33,403
|
30,614 |
| Current assets |
15,122
|
13,820
|
13,459 |
| Current liabilities |
11,190
|
4,114
|
3,063 |
| Equity capital |
25,960
|
27,650
|
25,906 |
| - share capital |
4,213
|
4,446
|
4,217 |
| Employees (average) |
0
|
0 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.1%
|
82.8%
|
84.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
| Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
| Current ratio |
135.1%
|
335.9%
|
439.4% |
| Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
| Change turnover |
1,127
|
2,271
|
2,380 |
| Change turnover % |
4%
|
9%
|
11% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.